Biocept: Michael Dugan, Nathaniel Sweed
Biocept has terminated the employment of Michael Dugan, its CMO and medical director, effective March 17, the firm said in a document filed with the US Securities and Exchange Commission. Biocept gave no reason for the action but said it has promoted Associate Medical Director Nathaniel Sweed to medical director and designated an undisclosed new medical director of the company's CLIA-certified, CAP-accredited clinical lab in San Diego. Dugan joined Biocept in August 2020.